23
Views
5
CrossRef citations to date
0
Altmetric
Original Article

An open and single-blind comparative assessment of unguentum cocois compound in the treatment of psoriasis of the scalp

, , &
Pages 159-161 | Received 01 Dec 1994, Accepted 21 Mar 1995, Published online: 12 Jul 2009
 

Abstract

The efficacy of Cocois Ointment, a standardized formulation of ung cocois co, in the treatment of moderate to severe scalp psoriasis was assessed in two stages: an open pilot study in 22 adult patients, and a multicentre single-blind randomized comparative study against a coal tar shampoo (Polytar) in 36 patients. In the comparative study, patients whose clinical assessment had failed to improve by more than 50% after 2 weeks were crossed over to the alternative treatment for a further 2 weeks. The proportion of patients showing improvement in the open-label study was highly significant (P 0.001; 95% confidence interval 0.77–1). In the comparative study, Cocois was significantly more effective than Polytar in removing scale (P = 0.01). The difference between the two treatments for erythema and plaque infiltration showed a trend in favour of Cocois, but this was not statistically significant. Overall assessment of treatment response showed that Cocois was superior to Polytar in both investigator and patient assessment. These results provide useful contemporary evidence on the efficacy of a traditional remedy, ung cocois co, in the treatment of psoriasis of the scalp.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.